Literature DB >> 18673278

Eosinophil-derived neurotoxin / RNase 2: connecting the past, the present and the future.

H F Rosenberg1.   

Abstract

The eosinophil-derived neurotoxin (EDN, also known as eosinophil protein-X) is best-known as one of the four major proteins found in the large specific granules of human eosinophilic leukocytes. Although it was named for its discovery and initial characterization as a neurotoxin, it is also expressed constitutively in human liver tissue and its expression can be induced in macrophages by proinflammatory stimuli. EDN and its divergent orthologs in rodents have ribonuclease activity, and are members of the extensive RNase A superfamily, although the relationship between the characterized physiologic functions and enzymatic activity remains poorly understood. Recent explorations into potential physiologic functions for EDN have provided us with some insights into its role in antiviral host defense, as a chemoattractant for human dendritic cells, and most recently, as an endogenous ligand for toll-like receptor (TLR)2.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18673278      PMCID: PMC2680432          DOI: 10.2174/138920108784567236

Source DB:  PubMed          Journal:  Curr Pharm Biotechnol        ISSN: 1389-2010            Impact factor:   2.837


  48 in total

1.  Differential recognition of TLR-dependent microbial ligands in human bronchial epithelial cells.

Authors:  Anja K Mayer; Mario Muehmer; Jörg Mages; Katja Gueinzius; Christian Hess; Klaus Heeg; Robert Bals; Roland Lang; Alexander H Dalpke
Journal:  J Immunol       Date:  2007-03-01       Impact factor: 5.422

Review 2.  The eosinophil.

Authors:  Marc E Rothenberg; Simon P Hogan
Journal:  Annu Rev Immunol       Date:  2006       Impact factor: 28.527

Review 3.  RNase A ribonucleases and host defense: an evolving story.

Authors:  Helene F Rosenberg
Journal:  J Leukoc Biol       Date:  2008-01-22       Impact factor: 4.962

4.  Human eosinophil-derived neurotoxin and eosinophil protein X are likely the same protein.

Authors:  N R Slifman; P Venge; C G Peterson; D J McKean; G J Gleich
Journal:  J Immunol       Date:  1989-10-01       Impact factor: 5.422

5.  Comparative toxicity of purified human eosinophil granule proteins for newborn larvae of Trichinella spiralis.

Authors:  K J Hamann; R L Barker; D A Loegering; G J Gleich
Journal:  J Parasitol       Date:  1987-06       Impact factor: 1.276

Review 6.  Eosinophil trafficking in allergy and asthma.

Authors:  Helene F Rosenberg; Simon Phipps; Paul S Foster
Journal:  J Allergy Clin Immunol       Date:  2007-05-03       Impact factor: 10.793

7.  Expression and characterization of recombinant human eosinophil-derived neurotoxin and eosinophil-derived neurotoxin-anti-transferrin receptor sFv.

Authors:  D L Newton; P J Nicholls; S M Rybak; R J Youle
Journal:  J Biol Chem       Date:  1994-10-28       Impact factor: 5.157

8.  Rapid evolution of a unique family of primate ribonuclease genes.

Authors:  H F Rosenberg; K D Dyer; H L Tiffany; M Gonzalez
Journal:  Nat Genet       Date:  1995-06       Impact factor: 38.330

9.  Biochemical and functional similarities between human eosinophil-derived neurotoxin and eosinophil cationic protein: homology with ribonuclease.

Authors:  G J Gleich; D A Loegering; M P Bell; J L Checkel; S J Ackerman; D J McKean
Journal:  Proc Natl Acad Sci U S A       Date:  1986-05       Impact factor: 11.205

10.  Eosinophil-derived neurotoxin acts as an alarmin to activate the TLR2-MyD88 signal pathway in dendritic cells and enhances Th2 immune responses.

Authors:  De Yang; Qian Chen; Shao Bo Su; Ping Zhang; Kahori Kurosaka; Rachel R Caspi; Suzanne M Michalek; Helene F Rosenberg; Ning Zhang; Joost J Oppenheim
Journal:  J Exp Med       Date:  2008-01-14       Impact factor: 14.307

View more
  26 in total

1.  Toward the Proteome of the Human Peripheral Blood Eosinophil.

Authors:  Christof Straub; Konrad Pazdrak; Travis W Young; Susan J Stafford; Zheng Wu; John E Wiktorowicz; Anthony M Haag; Robert D English; Kizhake V Soman; Alexander Kurosky
Journal:  Proteomics Clin Appl       Date:  2009       Impact factor: 3.494

2.  CCL11 elicits secretion of RNases from mouse eosinophils and their cell-free granules.

Authors:  Revital Shamri; Rossana C N Melo; Kristen M Young; Maytal Bivas-Benita; Jason J Xenakis; Lisa A Spencer; Peter F Weller
Journal:  FASEB J       Date:  2012-01-31       Impact factor: 5.191

Review 3.  Functional roles of the human ribonuclease A superfamily in RNA metabolism and membrane receptor biology.

Authors:  Heng-Huan Lee; Ying-Nai Wang; Mien-Chie Hung
Journal:  Mol Aspects Med       Date:  2019-03-25

4.  How does race and ethnicity effect the precision treatment of asthma?

Authors:  Ellen Zhang; Albert M Levin; L Keoki Williams
Journal:  Expert Rev Precis Med Drug Dev       Date:  2019-11-14

5.  A transcription factor map as revealed by a genome-wide gene expression analysis of whole-blood mRNA transcriptome in multiple sclerosis.

Authors:  Carlos Riveros; Drew Mellor; Kaushal S Gandhi; Fiona C McKay; Mathew B Cox; Regina Berretta; S Yahya Vaezpour; Mario Inostroza-Ponta; Simon A Broadley; Robert N Heard; Stephen Vucic; Graeme J Stewart; David W Williams; Rodney J Scott; Jeanette Lechner-Scott; David R Booth; Pablo Moscato
Journal:  PLoS One       Date:  2010-12-01       Impact factor: 3.240

6.  GATA transcription factors regulate the expression of the human eosinophil-derived neurotoxin (RNase 2) gene.

Authors:  Zhijun Qiu; Kimberly D Dyer; Zhihui Xie; Madeleine Rådinger; Helene F Rosenberg
Journal:  J Biol Chem       Date:  2009-03-10       Impact factor: 5.157

Review 7.  Damage-associated molecular patterns and their receptors in upper airway pathologies.

Authors:  Koen Van Crombruggen; Fenila Jacob; Nan Zhang; Claus Bachert
Journal:  Cell Mol Life Sci       Date:  2013-05-15       Impact factor: 9.261

Review 8.  Targeting eosinophils in allergy, inflammation and beyond.

Authors:  Patricia C Fulkerson; Marc E Rothenberg
Journal:  Nat Rev Drug Discov       Date:  2013-01-21       Impact factor: 84.694

9.  A fragment of the LG3 peptide of endorepellin is present in the urine of physically active mining workers: a potential marker of physical activity.

Authors:  Tony J Parker; Dayle L Sampson; Daniel Broszczak; Yee L Chng; Shea L Carter; David I Leavesley; Anthony W Parker; Zee Upton
Journal:  PLoS One       Date:  2012-03-23       Impact factor: 3.240

Review 10.  Eosinophils in skin diseases.

Authors:  Susanne Radonjic-Hoesli; Marie-Charlotte Brüggen; Laurence Feldmeyer; Hans-Uwe Simon; Dagmar Simon
Journal:  Semin Immunopathol       Date:  2021-06-07       Impact factor: 9.623

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.